Effects of biventricular support with Luo-Ye pump on hemodynamics during ischemic biventricular dysfunction.
- Author:
Huanlei HUANG
1
;
Xuejun XIAO
;
Ruixin FAN
;
Anheng CHENG
;
Wanmei GAO
Author Information
1. Department of Cardiovascular Surgery, Guangdong Provincial Cardiovascular Institute, Guanzhou 510100.
- Publication Type:Journal Article
- MeSH:
Animals;
Dogs;
Heart-Assist Devices;
Hemodynamics;
Myocardial Ischemia;
complications;
Ventricular Dysfunction;
etiology;
physiopathology;
surgery
- From:
Journal of Biomedical Engineering
2002;19(3):408-411
- CountryChina
- Language:Chinese
-
Abstract:
To compare the effects on hemodynamics of univentricular support with that of biventricular support on experimental ischemic biventricular dysfunction so as to provide experimental basis for clinical usage of the Luo-Ye pump. Eight canines were placed with a left ventricular assist device (LVAD; left atrial-aorta bypass) and a right ventricular assist device (RVAD; right atrial-pulmonary artery bypass). Left anterior descending coronary artery(LAD) was ligated, three minutes later, the proximal of right coronary artery (RCA) was ligated to establish animal madel of acute ischemic biventricular dysfunction. First start the LVAD, and then RVAD was started five minutes later. The hemodynamic data were recorded including central venous pressure(CVP), cardiac output (CO), mean artery pressure(MAP), and pulmonary artery pressure(PAP) and pulmonary capillary wedge pressure (PCWP). During biventricular assist devices (BVAD) the hemodynamics were improved remarkably, MAP increased from 37.4 +/- 8.8 mmHg to 84.2 +/- 9.7 mmHg (P < 0.01) (the normal level), CO increased from 0.82 +/- 0.1 L/min to 1.33 +/- 0.12 L/min (P < 0.01), CVP decreased from 14.6 +/- 2.3 cmH2O to 4.2 +/- 1.5 cmH2O (P < 0.01), PCWP decreased significantly from 14 +/- 3.9 mmHg to 1.6 +/- 0.9 mmHg. These data suggest that LVAD during biventricular dysfunction could not improve the hemodynamics to normal level. Howere BVAD could increase CO and MAP to normal level and decrease heart work and myocardial oxygen consumption, which could help to improve myocardial metabolism and myocardial function. Therefore, BVAD is the first choice in treating severe biventricular dysfunction which was not respond to drug therapy and intra-aortic balloon pump (IABP).
